NCT04134325 2025-04-16
Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma
UNC Lineberger Comprehensive Cancer Center
Phase EARLY_PHASE1 Active not recruiting
UNC Lineberger Comprehensive Cancer Center
Fox Chase Cancer Center
Presage Biosciences